MedPath

Role of MRI Diffusion in Differentiation Between Benign and Malignant Bony Lesions

Conditions
Efficacy of MRI Diffusion in Differentiation Between Benign and Malignant Bony Lesions
Interventions
Device: MRI
Registration Number
NCT03463291
Lead Sponsor
Assiut University
Brief Summary

Bone tumors are categorized according to their tissue of origin into cartilagenous, osteogenic, fibrogenic, fibrohistiocytic, haematopoietic, vascular, and lipogenic tumors.

Magnetic resonance imaging (MRI) is now indispensable for the preoperative workup and therapeutic follow-up of patients with musculoskeletal tumors.

The application of DW-MRI in bone marrow is today an established examination technique that provides a unique contrast and that can help in the detection of bone-marrow pathologies and the differentiation of benign and malignant bone-marrow lesions.

Diffusion MRI provides quantitative and qualitative assessments of tissue cellularity and cell-membrane integrity. It is widely used for tumour detection, characterisation, and monitoring during treatment. Diffusion MRI supplies functional information that complements the structural evaluation.

In combination with standard structural MRI parameters, the ADC value improves tumour characterization. Diffusion MRI can also be used to monitor tumours during chemotherapy. Tumour necrosis results in loss of cell membrane integrity and in expansion of the extracellular compartment, leading to greater water-molecule diffusion with an increase in the ADC value.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • All patients with bony lesions will be included in the study.
Read More
Exclusion Criteria
  • Patient with cardiac pacemaker.
  • Patients with metallic prosthesis in the region of examination.
  • Patients with claustrophobia.
  • Patient with recent history of surgical or imagining guided biopsy from the bony lesion.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Study groupMRIAll patients with bony lesions
Primary Outcome Measures
NameTimeMethod
The ADC value of MRI diffusion in benign and malignant bony lesions ( considering ADC value <1.2 ..malignant while ADC>1.2 ..benign)1 day
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath